ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,254Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1802

$467K Total Retail Price of All Prescriptions

Rank: 115 out of 1802

490 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 659 624 1 1
LEVOTHYROXINE SODIUM 411 375 2 2
HYDROCHLOROTHIAZIDE 406 385 3 8
METFORMIN HCL 271 261 4 11
LISINOPRIL 269 263 5 3
WARFARIN SODIUM 259 241 6 7
METOPROLOL TARTRATE 258 254 7 9
OMEPRAZOLE 249 221 8 4
ATORVASTATIN CALCIUM 241 220 9 14
SERTRALINE HCL 225 209 10 20
ATENOLOL 201 178 11 12
FLUTICASONE PROPIONATE 200 187 12 37
CITALOPRAM HBR 185 165 13 17
AMLODIPINE BESYLATE 181 181 14 6
POTASSIUM CHLORIDE 163 162 15 15
FUROSEMIDE 159 147 16 5
LOSARTAN-HYDROCHLOROTHIAZIDE 158 148 17 52
LOSARTAN POTASSIUM 137 135 18 18
CRESTOR 126 112 19 31
LOVASTATIN 123 123 20 25
ALENDRONATE SODIUM 120 109 21 21
ADVAIR DISKUS 92 48 22 32
METOPROLOL SUCCINATE 82 81 23 13
PANTOPRAZOLE SODIUM 80 68 24 44
HYDROCODONE-ACETAMINOPHEN 75 54 S3 25 10
BENAZEPRIL HCL 66 55 26 61
GLYBURIDE 66 66 R 26 68
TRAMADOL HCL 65 65 28 22
DIOVAN HCT 65 54 28 163
ALLOPURINOL 62 62 30 24
SPIRONOLACTONE 62 50 30 53
VYTORIN 62 61 30 194
ZOLPIDEM TARTRATE 59 53 33 27
FENOFIBRATE 58 54 34 56
QUINAPRIL HCL 57 57 35 122
ZETIA 56 45 36 79
CLOPIDOGREL 56 56 36 48
PROPRANOLOL HCL 53 53 38 115
TAMSULOSIN HCL 51 51 39 28
RANITIDINE HCL 50 48 40 30
GLIPIZIDE 50 50 40 51
NIASPAN 50 27 40 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.